Cargando…

Controlled ovarian hyperstimulation for fertility preservation in women with breast cancer: Practical issues

In Korean women, a westernized lifestyle is associated with an increased risk of breast cancer. Fertility preservation has become an increasingly important issue for women with breast cancer, in accordance with substantial improvements in survival rate after cancer treatment. The methods of controll...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, So Yun, Jeong, Kyungah, Cho, Eun Hye, Chung, Hye Won
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society for Reproductive Medicine 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7943346/ https://www.ncbi.nlm.nih.gov/pubmed/33131234 http://dx.doi.org/10.5653/cerm.2020.03594

Ejemplares similares

What is the role of robotic surgery in ovarian cystectomy with fertility preservation?
por: Lee, Ju Hye, et al.
Publicado: (2023)

Clinical experience of robotic myomectomy for fertility preservation using preoperative magnetic resonance imaging predictor
por: Park, So Yun, et al.
Publicado: (2020)

Risk of ovarian hyperstimulation syndrome in women with malignancies undergoing treatment with long-acting gonadotropin-releasing hormone agonist after controlled ovarian hyperstimulation for fertility preservation: a systematic review
por: Ingold, Caroline, et al.
Publicado: (2023)

Use of medroxyprogesterone acetate in women with ovarian endometriosis undergoing controlled ovarian hyperstimulation for in vitro fertilization
por: Guo, Haiyan, et al.
Publicado: (2017)

The Association of Ovarian Reserve with Exposure to Bisphenol A and Phthalate in Reproductive-aged Women
por: Park, So Yun, et al.
Publicado: (2020)

Serum Anti-Müllerian Hormone Levels before Surgery in Patients with Ovarian Endometriomas Compared to Other Benign Ovarian Cysts
por: Jeon, Ji Hyun, et al.
Publicado: (2015)

Severe Ovarian Hyperstimulation Syndrome in the Setting of In Vitro Fertilization Treatment
por: Diaz Ayllon, Hannia, et al.
Publicado: (2023)

Outcomes of Controlled Ovarian Hyperstimulation/In Vitro Fertilization for Infertile Patients with Borderline Ovarian Tumor after Conservative Treatment
por: Park, Chan Woo, et al.
Publicado: (2007)

Diagnostic Usefulness of Transrectal Ultrasound Compared with Transvaginal Ultrasound Assessment in Young Korean Women with Polycystic Ovary Syndrome
por: Lee, Da Eun, et al.
Publicado: (2015)

Ovarian hyperstimulation syndrome
por: Kumar, Pratap, et al.
Publicado: (2011)

Ovarian and intellectual hyperstimulation
por: Quaas, Alexander M.
Publicado: (2021)

Comparative Effectiveness of Three Ovarian Hyperstimulation Protocol in In Vitro Fertilization (IVF) Cycles for Women with Polycystic Ovary Syndrome
por: Chen, Yilu, et al.
Publicado: (2018)

Clinical and Biochemical Profiles according to Homeostasis Model Assessment-insulin Resistance (HOMA-IR) in Korean Women with Polycystic Ovary Syndrome
por: Lee, Da Eun, et al.
Publicado: (2014)

Blood cadmium and volume of uterine fibroids in premenopausal women
por: Ye, Shinhee, et al.
Publicado: (2017)

Fertility preservation in women—a practical guide to preservation techniques and therapeutic strategies in breast cancer, Hodgkin’s lymphoma and borderline ovarian tumours by the fertility preservation network FertiPROTEKT
por: von Wolff, Michael, et al.
Publicado: (2011)

AGAINST: Fertility preservation for women with ovarian endometriosis: it is time to adopt this as routine practice
por: Hirsch, Martin, et al.
Publicado: (2022)

Clinical experience of long-term use of dienogest after surgery for ovarian endometrioma
por: Chandra, Anjali, et al.
Publicado: (2018)

Changes in Coagulation and Fibrinolytic Indices in Women with Polycystic Ovarian Syndrome Undergoing Controlled Ovarian Hyperstimulation
por: Huang, Ying, et al.
Publicado: (2014)

Early onset ovarian hyperstimulation syndrome despite use of segmentation approach and ovarian hyperstimulation syndrome prophylaxis
por: Mahajan, Nalini, et al.
Publicado: (2015)

Tamoxifen-induced ovarian hyperstimulation during premenopausal hormonal therapy for breast cancer in Japanese women
por: Yamazaki, Rena, et al.
Publicado: (2015)

Tubercular Ascites Simulating Ovarian Hyperstimulation Syndrome following In Vitro Fertilization and Embryo Transfer Pregnancy
por: Ramachandran, Amar, et al.
Publicado: (2013)

In-vitro fertilization resulting in heterotopic pregnancy, ovarian hyperstimulation and paralytic ileus: A case report
por: Madžarac, Vedran, et al.
Publicado: (2019)

Fertility preservation in women with cervical, endometrial or ovarian cancers
por: Feichtinger, Michael, et al.
Publicado: (2016)

Fertility Preservation in Young Women With Breast Cancer: A Review
por: Hong, Yeon Hee, et al.
Publicado: (2023)

Utrogestan as an Effective Oral Alternative for Preventing Premature Luteinizing Hormone Surges in Women Undergoing Controlled Ovarian Hyperstimulation for In Vitro Fertilization
por: Zhu, Xiuxian, et al.
Publicado: (2015)

Prediction of severe ovarian hyperstimulation syndrome in women undergoing in vitro fertilization using estradiol levels, collected ova, and number of follicles
por: Madrazo, Ivan, et al.
Publicado: (2020)

Plasma pentraxin 3 is higher in early ovarian hyperstimulation syndrome than in uncomplicated in vitro fertilization cycle of high-risk women
por: Korhonen, Kati, et al.
Publicado: (2020)

Ovarian Hyperstimulation Syndrome, the Master of Disguise?
por: Ironside, Emily Charlotte, et al.
Publicado: (2015)

GDF9 polymorphisms: influence on ovarian response in women undergoing controlled ovarian hyperstimulation
por: Bilibio, João Paolo, et al.
Publicado: (2020)

Impacts of medroxyprogesterone acetate on oocytes and embryos: matched case-control study in women with stage III–IV ovarian endometriosis undergoing controlled ovarian hyperstimulation for in vitro fertilization
por: Guo, Haiyan, et al.
Publicado: (2020)

Cut-Off Levels of Anti-Mullerian Hormone for The Prediction of Ovarian Response, In Vitro Fertilization Outcome and Ovarian Hyperstimulation Syndrome
por: Salmassi, Ali, et al.
Publicado: (2015)

Does the serum E2 level change following coasting treatment strategy to prevent ovarian hyperstimulation syndrome impact cycle outcomes during controlled ovarian hyperstimulation and in vitro fertilization procedure?
por: Yumuşak, Ömer Hamid, et al.
Publicado: (2014)

Renal and Hepatic Functions after A Week of Controlled Ovarian Hyperstimulation during In Vitro Fertilization Cycles
por: Romito, Ilaria, et al.
Publicado: (2017)

Clinical efficacy of a novel method of fertility-preserving adenomyomectomy in infertile women with diffuse adenomyosis
por: Yoon, Sang Ho, et al.
Publicado: (2023)

Serum Antimüllerian hormone does not predict elevated progesterone levels among women who undergo controlled ovarian hyperstimulation for in vitro fertilization
por: Kavoussi, Shahryar K., et al.
Publicado: (2019)

Letrozole-associated controlled ovarian hyperstimulation in breast cancer patients versus conventional controlled ovarian hyperstimulation in infertile patients: assessment of oocyte quality related biomarkers
por: Goldrat, Oranite, et al.
Publicado: (2019)

Fertility preservation in ovarian tumours
por: Tomao, Federica, et al.
Publicado: (2018)

The Effectiveness of Cabergoline for the Prevention of Ovarian Hyperstimulation Syndrome
por: Hosseini, Marzieh Agha, et al.
Publicado: (2011)

Ovarian Hyperstimulation Syndrome as an Etiology of Obstructive Uropathy
por: Marak, Creticus P., et al.
Publicado: (2013)

Radiological Illustration of Spontaneous Ovarian Hyperstimulation Syndrome
por: Mittal, Kartik, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_bl1oba1mqcci2lnuvcgeolbiuf